First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE

Published

News published by Renovion Inc. concerning ARINA-1, administered via an optimized investigational eFlow® Technology nebulizer.
 

Read the press release

Back to overview